The Treatment of Hallucinations in Schizophrenia Spectrum Disorders
Identifieur interne : 001073 ( Ncbi/Curation ); précédent : 001072; suivant : 001074The Treatment of Hallucinations in Schizophrenia Spectrum Disorders
Auteurs : Iris E. C. Sommer [Pays-Bas] ; Christina W. Slotema [Pays-Bas] ; Zafiris J. Daskalakis [Canada] ; Eske M. Derks [Pays-Bas] ; Jan Dirk Blom [Pays-Bas] ; Mark Van Der Gaag [Pays-Bas]Source :
- Schizophrenia Bulletin [ 0586-7614 ] ; 2012.
Abstract
This article reviews the treatment of hallucinations in schizophrenia. The first treatment option for hallucinations in schizophrenia is antipsychotic medication, which can induce a rapid decrease in severity. Only 8% of first-episode patients still experience mild to moderate hallucinations after continuing medication for 1 year. Olanzapine, amisulpride, ziprasidone, and quetiapine are equally effective against hallucinations, but haloperidol may be slightly inferior. If the drug of first choice provides inadequate improvement, it is probably best to switch medication after 2–4 weeks of treatment. Clozapine is the drug of choice for patients who are resistant to 2 antipsychotic agents. Blood levels should be above 350–450 μg/ml for maximal effect. For relapse prevention, medication should be continued in the same dose. Depot medication should be considered for all patients because nonadherence is high. Cognitive-behavioral therapy (CBT) can be applied as an augmentation to antipsychotic medication. The success of CBT depends on the reduction of catastrophic appraisals, thereby reducing the concurrent anxiety and distress. CBT aims at reducing the emotional distress associated with auditory hallucinations and develops new coping strategies. Transcranial magnetic stimulation (TMS) is capable of reducing the frequency and severity of auditory hallucinations. Several meta-analyses found significantly better symptom reduction for low-frequency repetitive TMS as compared with placebo. Consequently, TMS currently has the status of a potentially useful treatment method for auditory hallucinations, but only in combination with state of the art antipsychotic treatment. Electroconvulsive therapy (ECT) is considered a last resort for treatment-resistant psychosis. Although several studies showed clinical improvement, a specific reduction in hallucination severity has never been demonstrated.
Url:
DOI: 10.1093/schbul/sbs034
PubMed: 22368234
PubMed Central: 3577047
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000681
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :000681
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000752
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001073
Links to Exploration step
PMC:3577047Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Treatment of Hallucinations in Schizophrenia Spectrum Disorders</title>
<author><name sortKey="Sommer, Iris E C" sort="Sommer, Iris E C" uniqKey="Sommer I" first="Iris E. C." last="Sommer">Iris E. C. Sommer</name>
<affiliation wicri:level="3"><nlm:aff id="aff1">Neuroscience Division, Psychiatry Department, University Medical Centre Utrecht & Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Neuroscience Division, Psychiatry Department, University Medical Centre Utrecht & Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Slotema, Christina W" sort="Slotema, Christina W" uniqKey="Slotema C" first="Christina W." last="Slotema">Christina W. Slotema</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Parnassia Bavo Group, The Hague, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Parnassia Bavo Group, The Hague</wicri:regionArea>
<wicri:noRegion>The Hague</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Daskalakis, Zafiris J" sort="Daskalakis, Zafiris J" uniqKey="Daskalakis Z" first="Zafiris J." last="Daskalakis">Zafiris J. Daskalakis</name>
<affiliation wicri:level="4"><nlm:aff id="aff3">Department of Psychiatry, University of Toronto, Toronto, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Psychiatry, University of Toronto, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff4">Centre for Addiction and Mental Health, Toronto, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Centre for Addiction and Mental Health, Toronto</wicri:regionArea>
<wicri:noRegion>Toronto</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Derks, Eske M" sort="Derks, Eske M" uniqKey="Derks E" first="Eske M." last="Derks">Eske M. Derks</name>
<affiliation wicri:level="3"><nlm:aff id="aff1">Neuroscience Division, Psychiatry Department, University Medical Centre Utrecht & Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Neuroscience Division, Psychiatry Department, University Medical Centre Utrecht & Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Blom, Jan Dirk" sort="Blom, Jan Dirk" uniqKey="Blom J" first="Jan Dirk" last="Blom">Jan Dirk Blom</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Parnassia Bavo Group, The Hague, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Parnassia Bavo Group, The Hague</wicri:regionArea>
<wicri:noRegion>The Hague</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:aff id="aff5">Department of Psychiatry, University of Groningen, Groningen, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Department of Psychiatry, University of Groningen, Groningen</wicri:regionArea>
<placeName><settlement type="city">Groningue</settlement>
<region nuts="2" type="province">Groningue (province)</region>
<settlement type="city">Groningue (ville)</settlement>
</placeName>
<orgName type="university">Université de Groningue</orgName>
</affiliation>
</author>
<author><name sortKey="Van Der Gaag, Mark" sort="Van Der Gaag, Mark" uniqKey="Van Der Gaag M" first="Mark" last="Van Der Gaag">Mark Van Der Gaag</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Parnassia Bavo Group, The Hague, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Parnassia Bavo Group, The Hague</wicri:regionArea>
<wicri:noRegion>The Hague</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><nlm:aff id="aff6">VU University and EMGO+ Institute for Health and Care Research, VU University, Amsterdam, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>VU University and EMGO+ Institute for Health and Care Research, VU University, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">22368234</idno>
<idno type="pmc">3577047</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577047</idno>
<idno type="RBID">PMC:3577047</idno>
<idno type="doi">10.1093/schbul/sbs034</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000681</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000681</idno>
<idno type="wicri:Area/Pmc/Curation">000681</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000681</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000752</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000752</idno>
<idno type="wicri:Area/Ncbi/Merge">001073</idno>
<idno type="wicri:Area/Ncbi/Curation">001073</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">The Treatment of Hallucinations in Schizophrenia Spectrum Disorders</title>
<author><name sortKey="Sommer, Iris E C" sort="Sommer, Iris E C" uniqKey="Sommer I" first="Iris E. C." last="Sommer">Iris E. C. Sommer</name>
<affiliation wicri:level="3"><nlm:aff id="aff1">Neuroscience Division, Psychiatry Department, University Medical Centre Utrecht & Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Neuroscience Division, Psychiatry Department, University Medical Centre Utrecht & Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Slotema, Christina W" sort="Slotema, Christina W" uniqKey="Slotema C" first="Christina W." last="Slotema">Christina W. Slotema</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Parnassia Bavo Group, The Hague, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Parnassia Bavo Group, The Hague</wicri:regionArea>
<wicri:noRegion>The Hague</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Daskalakis, Zafiris J" sort="Daskalakis, Zafiris J" uniqKey="Daskalakis Z" first="Zafiris J." last="Daskalakis">Zafiris J. Daskalakis</name>
<affiliation wicri:level="4"><nlm:aff id="aff3">Department of Psychiatry, University of Toronto, Toronto, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Psychiatry, University of Toronto, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff4">Centre for Addiction and Mental Health, Toronto, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Centre for Addiction and Mental Health, Toronto</wicri:regionArea>
<wicri:noRegion>Toronto</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Derks, Eske M" sort="Derks, Eske M" uniqKey="Derks E" first="Eske M." last="Derks">Eske M. Derks</name>
<affiliation wicri:level="3"><nlm:aff id="aff1">Neuroscience Division, Psychiatry Department, University Medical Centre Utrecht & Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Neuroscience Division, Psychiatry Department, University Medical Centre Utrecht & Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Blom, Jan Dirk" sort="Blom, Jan Dirk" uniqKey="Blom J" first="Jan Dirk" last="Blom">Jan Dirk Blom</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Parnassia Bavo Group, The Hague, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Parnassia Bavo Group, The Hague</wicri:regionArea>
<wicri:noRegion>The Hague</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:aff id="aff5">Department of Psychiatry, University of Groningen, Groningen, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Department of Psychiatry, University of Groningen, Groningen</wicri:regionArea>
<placeName><settlement type="city">Groningue</settlement>
<region nuts="2" type="province">Groningue (province)</region>
<settlement type="city">Groningue (ville)</settlement>
</placeName>
<orgName type="university">Université de Groningue</orgName>
</affiliation>
</author>
<author><name sortKey="Van Der Gaag, Mark" sort="Van Der Gaag, Mark" uniqKey="Van Der Gaag M" first="Mark" last="Van Der Gaag">Mark Van Der Gaag</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Parnassia Bavo Group, The Hague, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Parnassia Bavo Group, The Hague</wicri:regionArea>
<wicri:noRegion>The Hague</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><nlm:aff id="aff6">VU University and EMGO+ Institute for Health and Care Research, VU University, Amsterdam, the Netherlands</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>VU University and EMGO+ Institute for Health and Care Research, VU University, Amsterdam</wicri:regionArea>
<placeName><settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Schizophrenia Bulletin</title>
<idno type="ISSN">0586-7614</idno>
<idno type="eISSN">1745-1701</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>This article reviews the treatment of hallucinations in schizophrenia. The first treatment option for hallucinations in schizophrenia is antipsychotic medication, which can induce a rapid decrease in severity. Only 8% of first-episode patients still experience mild to moderate hallucinations after continuing medication for 1 year. Olanzapine, amisulpride, ziprasidone, and quetiapine are equally effective against hallucinations, but haloperidol may be slightly inferior. If the drug of first choice provides inadequate improvement, it is probably best to switch medication after 2–4 weeks of treatment. Clozapine is the drug of choice for patients who are resistant to 2 antipsychotic agents. Blood levels should be above 350–450 μg/ml for maximal effect. For relapse prevention, medication should be continued in the same dose. Depot medication should be considered for all patients because nonadherence is high. Cognitive-behavioral therapy (CBT) can be applied as an augmentation to antipsychotic medication. The success of CBT depends on the reduction of catastrophic appraisals, thereby reducing the concurrent anxiety and distress. CBT aims at reducing the emotional distress associated with auditory hallucinations and develops new coping strategies. Transcranial magnetic stimulation (TMS) is capable of reducing the frequency and severity of auditory hallucinations. Several meta-analyses found significantly better symptom reduction for low-frequency repetitive TMS as compared with placebo. Consequently, TMS currently has the status of a potentially useful treatment method for auditory hallucinations, but only in combination with state of the art antipsychotic treatment. Electroconvulsive therapy (ECT) is considered a last resort for treatment-resistant psychosis. Although several studies showed clinical improvement, a specific reduction in hallucination severity has never been demonstrated.</p>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001073 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001073 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Ncbi |étape= Curation |type= RBID |clé= PMC:3577047 |texte= The Treatment of Hallucinations in Schizophrenia Spectrum Disorders }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:22368234" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
This area was generated with Dilib version V0.6.29. |